Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
CNS & Neurological Disorders Drug Targets
|
May 13, 2022
Elucidating the Role of Trauma and Significant Life Stress in the Disease of Addiction may Provide New Targets for Medication Development
Caroline E Sagrera, Laura Alderman, M Frances Vest, et al.
Pharmacology, Biochemistry, and Behavior
|
September 6, 2025
Swiss-Webster and C57BL/6 mice are differentially sensitive to the stimulant effects of methamphetamine
Bo Jarrett Wood, Nicole M Hall, M Frances Vest, et al.
AAPS Pharmscitech
|
May 7, 2021
Formulation and Characterization of Microcapsules Encapsulating PC12 Cells as a Prospective Treatment Approach for Parkinson's Disease
Devyani J Joshi, Neha M Chitre, Amit Bansal, et al.
Psychopharmacology
|
July 17, 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
Aboagyewaah Oppong-Damoah, Kristen E Curry, Bruce E Blough, et al.
International Journal of Pharmaceutics
|
August 21, 2018
Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch
Sindhu S Ganti, Sonalika A Bhattaccharjee, Kevin S Murnane, et al.
Psychopharmacology
|
May 12, 2009
Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys
Matthew L Banks, Monica L Andersen, Kevin S Murnane, et al.
Psychopharmacology
|
April 14, 2010
Dopamine transporter-related effects of modafinil in rhesus monkeys
Monica L Andersen, Eileen Kessler, Kevin S Murnane, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 6, 2025
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
Jacob S Aday, Brian S Barnett, Dan Grossman, et al.
Pharmaceutics
|
April 26, 2025
Microfluidics-Assisted Formulation of Polymeric Oxytocin Nanoparticles for Targeted Brain Delivery
Emmanuel Adediran, Sharon Vijayanand, Akanksha Kale, et al.
Frontiers in Psychiatry
|
July 28, 2025
Individuals recently abstinent from methamphetamine show selective cognitive and behavioral differences when compared to age-matched controls
M Frances Vest, Alexandru Mihai Dumitrescu, Matthew W Johnson, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
CNS & Neurological Disorders Drug Targets
|
May 13, 2022
Elucidating the Role of Trauma and Significant Life Stress in the Disease of Addiction may Provide New Targets for Medication Development
Caroline E Sagrera, Laura Alderman, M Frances Vest, et al.
Pharmacology, Biochemistry, and Behavior
|
September 6, 2025
Swiss-Webster and C57BL/6 mice are differentially sensitive to the stimulant effects of methamphetamine
Bo Jarrett Wood, Nicole M Hall, M Frances Vest, et al.
AAPS Pharmscitech
|
May 7, 2021
Formulation and Characterization of Microcapsules Encapsulating PC12 Cells as a Prospective Treatment Approach for Parkinson's Disease
Devyani J Joshi, Neha M Chitre, Amit Bansal, et al.
Psychopharmacology
|
July 17, 2019
Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice
Aboagyewaah Oppong-Damoah, Kristen E Curry, Bruce E Blough, et al.
International Journal of Pharmaceutics
|
August 21, 2018
Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch
Sindhu S Ganti, Sonalika A Bhattaccharjee, Kevin S Murnane, et al.
Psychopharmacology
|
May 12, 2009
Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys
Matthew L Banks, Monica L Andersen, Kevin S Murnane, et al.
Psychopharmacology
|
April 14, 2010
Dopamine transporter-related effects of modafinil in rhesus monkeys
Monica L Andersen, Eileen Kessler, Kevin S Murnane, et al.
Psychedelic Medicine (New Rochelle, N.Y.)
|
March 6, 2025
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
Jacob S Aday, Brian S Barnett, Dan Grossman, et al.
Pharmaceutics
|
April 26, 2025
Microfluidics-Assisted Formulation of Polymeric Oxytocin Nanoparticles for Targeted Brain Delivery
Emmanuel Adediran, Sharon Vijayanand, Akanksha Kale, et al.
Frontiers in Psychiatry
|
July 28, 2025
Individuals recently abstinent from methamphetamine show selective cognitive and behavioral differences when compared to age-matched controls
M Frances Vest, Alexandru Mihai Dumitrescu, Matthew W Johnson, et al.
Page
of 9